Skip to content

The new way prosecutors are using an old act

And how it's affecting drug CEOs

[jwp-video n="1"]

As the effects of the opioid crisis are felt across the country, federal prosecutors are taking action and prosecuting CEOs of pharmaceutical companies. The Controlled Substance Act is one of their most novel weapons. 

Watch as CQ Roll Call’s senior multimedia producer Jinitzail Hernández explains how.  

[jwp-video n=”1″]

Recent Stories

Trump heads to Dallas convention ahead of promised 30-day campaign blitz

NRCC adds 5 more candidates to ‘MAGA Majority’ program

At the Races: Don’t take it for Granite

Pappas keeps focus on November amid signs of tightening Senate primary

Capitol Lens — Stumping in New England

Behind the Byline — The House’s CR week and skating out of town